Ral Guanine Nucleotide Dissociation Stimulator (RALGDS) (N-Term) Peptid
RALGDS
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN982633
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Ral Guanine Nucleotide Dissociation Stimulator (RALGDS) (N-Term) Peptid (ABIN982633)
Target
RALGDS
(Ral Guanine Nucleotide Dissociation Stimulator (RALGDS))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RALGDS antibody (Catalog #: ARP56275_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RALGDS (Ral Guanine Nucleotide Dissociation Stimulator (RALGDS))
-
Hintergrund
-
The specific function of this protein remains unknown.
Alias Symbols: FLJ20922, RGF, RalGEF, RGDS
Protein Interaction Partner: HRAS,MAPK3,RAP1A,ARRB1,ARRB2,CNKSR1,HRAS,KRAS,MAPK3,MLLT4,MRAS,NF2,PDPK1,RAP1A,RAP1GAP,RAP2A,RAP2B,RIT1,RIT2,RRAS,RRAS2,ARRB1,ARRB2,CNKSR1,HRAS,KRAS,LRPAP1,MRAS,PDK1,RAP1A,RAP2A,RAP2B,RAPGEF2,RIN1,RIT1,RRAS,RRAS2
Protein Size: 859 -
Molekulargewicht
- 95 kDa
-
Gen-ID
- 5900
-
NCBI Accession
- NM_001042368, NP_001035827
-
UniProt
- Q6KH11
Target
-
Sie sind hier:
